nodes	percent_of_prediction	percent_of_DWPC	metapath
Rufinamide—ALB—chronic obstructive pulmonary disease	0.409	1	CbGaD
Rufinamide—CYP2E1—Aminophylline—chronic obstructive pulmonary disease	0.0967	0.318	CbGbCtD
Rufinamide—ALB—Prednisone—chronic obstructive pulmonary disease	0.0462	0.152	CbGbCtD
Rufinamide—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0455	0.149	CbGbCtD
Rufinamide—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0307	0.101	CbGbCtD
Rufinamide—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0293	0.0963	CbGbCtD
Rufinamide—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0261	0.0858	CbGbCtD
Rufinamide—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0153	0.0504	CbGbCtD
Rufinamide—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0145	0.0476	CbGbCtD
Rufinamide—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.00104	0.00419	CcSEcCtD
Rufinamide—Urethral disorder—Tiotropium—chronic obstructive pulmonary disease	0.00103	0.00418	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00103	0.00416	CcSEcCtD
Rufinamide—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.00103	0.00416	CcSEcCtD
Rufinamide—Bronchitis—Arformoterol—chronic obstructive pulmonary disease	0.00102	0.00414	CcSEcCtD
Rufinamide—Bronchitis—Formoterol—chronic obstructive pulmonary disease	0.00102	0.00414	CcSEcCtD
Rufinamide—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.00102	0.00412	CcSEcCtD
Rufinamide—Influenza—Salbutamol—chronic obstructive pulmonary disease	0.001	0.00406	CcSEcCtD
Rufinamide—Bronchitis—Montelukast—chronic obstructive pulmonary disease	0.001	0.00405	CcSEcCtD
Rufinamide—Eye disorder—Tiotropium—chronic obstructive pulmonary disease	0.000986	0.00399	CcSEcCtD
Rufinamide—Bronchitis—Salbutamol—chronic obstructive pulmonary disease	0.000966	0.00391	CcSEcCtD
Rufinamide—Immune system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000953	0.00385	CcSEcCtD
Rufinamide—Mediastinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00095	0.00385	CcSEcCtD
Rufinamide—Dysuria—Salbutamol—chronic obstructive pulmonary disease	0.000939	0.0038	CcSEcCtD
Rufinamide—Pneumonia—Montelukast—chronic obstructive pulmonary disease	0.000934	0.00378	CcSEcCtD
Rufinamide—Infestation NOS—Montelukast—chronic obstructive pulmonary disease	0.000929	0.00376	CcSEcCtD
Rufinamide—Infestation—Montelukast—chronic obstructive pulmonary disease	0.000929	0.00376	CcSEcCtD
Rufinamide—Mental disorder—Tiotropium—chronic obstructive pulmonary disease	0.000924	0.00374	CcSEcCtD
Rufinamide—Malnutrition—Tiotropium—chronic obstructive pulmonary disease	0.000918	0.00371	CcSEcCtD
Rufinamide—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.000912	0.00369	CcSEcCtD
Rufinamide—Haematuria—Formoterol—chronic obstructive pulmonary disease	0.000904	0.00366	CcSEcCtD
Rufinamide—Haematuria—Arformoterol—chronic obstructive pulmonary disease	0.000904	0.00366	CcSEcCtD
Rufinamide—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.000895	0.00362	CcSEcCtD
Rufinamide—Sinusitis—Formoterol—chronic obstructive pulmonary disease	0.00089	0.0036	CcSEcCtD
Rufinamide—Sinusitis—Arformoterol—chronic obstructive pulmonary disease	0.00089	0.0036	CcSEcCtD
Rufinamide—Back pain—Tiotropium—chronic obstructive pulmonary disease	0.000888	0.00359	CcSEcCtD
Rufinamide—Hepatobiliary disease—Montelukast—chronic obstructive pulmonary disease	0.000878	0.00355	CcSEcCtD
Rufinamide—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000878	0.00355	CcSEcCtD
Rufinamide—Epistaxis—Montelukast—chronic obstructive pulmonary disease	0.000876	0.00354	CcSEcCtD
Rufinamide—Sinusitis—Montelukast—chronic obstructive pulmonary disease	0.000871	0.00353	CcSEcCtD
Rufinamide—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.000865	0.0035	CcSEcCtD
Rufinamide—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000855	0.00346	CcSEcCtD
Rufinamide—Haematuria—Salbutamol—chronic obstructive pulmonary disease	0.000854	0.00345	CcSEcCtD
Rufinamide—Rhinitis—Arformoterol—chronic obstructive pulmonary disease	0.000853	0.00345	CcSEcCtD
Rufinamide—Rhinitis—Formoterol—chronic obstructive pulmonary disease	0.000853	0.00345	CcSEcCtD
Rufinamide—Epistaxis—Salbutamol—chronic obstructive pulmonary disease	0.000844	0.00342	CcSEcCtD
Rufinamide—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.000843	0.00341	CcSEcCtD
Rufinamide—Urinary tract disorder—Arformoterol—chronic obstructive pulmonary disease	0.000841	0.0034	CcSEcCtD
Rufinamide—Urinary tract disorder—Formoterol—chronic obstructive pulmonary disease	0.000841	0.0034	CcSEcCtD
Rufinamide—Sinusitis—Salbutamol—chronic obstructive pulmonary disease	0.00084	0.0034	CcSEcCtD
Rufinamide—Rhinitis—Montelukast—chronic obstructive pulmonary disease	0.000836	0.00338	CcSEcCtD
Rufinamide—Urethral disorder—Arformoterol—chronic obstructive pulmonary disease	0.000834	0.00338	CcSEcCtD
Rufinamide—Urethral disorder—Formoterol—chronic obstructive pulmonary disease	0.000834	0.00338	CcSEcCtD
Rufinamide—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.000826	0.00334	CcSEcCtD
Rufinamide—Urinary tract disorder—Montelukast—chronic obstructive pulmonary disease	0.000823	0.00333	CcSEcCtD
Rufinamide—Urethral disorder—Montelukast—chronic obstructive pulmonary disease	0.000817	0.00331	CcSEcCtD
Rufinamide—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000815	0.0033	CcSEcCtD
Rufinamide—Rhinitis—Salbutamol—chronic obstructive pulmonary disease	0.000806	0.00326	CcSEcCtD
Rufinamide—Urinary tract disorder—Salbutamol—chronic obstructive pulmonary disease	0.000794	0.00321	CcSEcCtD
Rufinamide—Acne—Prednisone—chronic obstructive pulmonary disease	0.000793	0.00321	CcSEcCtD
Rufinamide—Cardiac disorder—Arformoterol—chronic obstructive pulmonary disease	0.00079	0.0032	CcSEcCtD
Rufinamide—Cardiac disorder—Formoterol—chronic obstructive pulmonary disease	0.00079	0.0032	CcSEcCtD
Rufinamide—Infection—Aminophylline—chronic obstructive pulmonary disease	0.000789	0.00319	CcSEcCtD
Rufinamide—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000788	0.00319	CcSEcCtD
Rufinamide—Urethral disorder—Salbutamol—chronic obstructive pulmonary disease	0.000788	0.00319	CcSEcCtD
Rufinamide—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.000779	0.00315	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.000776	0.00314	CcSEcCtD
Rufinamide—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.000774	0.00313	CcSEcCtD
Rufinamide—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.000769	0.00311	CcSEcCtD
Rufinamide—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000769	0.00311	CcSEcCtD
Rufinamide—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000767	0.0031	CcSEcCtD
Rufinamide—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000767	0.0031	CcSEcCtD
Rufinamide—Contusion—Prednisone—chronic obstructive pulmonary disease	0.000764	0.00309	CcSEcCtD
Rufinamide—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000758	0.00307	CcSEcCtD
Rufinamide—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.000757	0.00306	CcSEcCtD
Rufinamide—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.000753	0.00305	CcSEcCtD
Rufinamide—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000751	0.00304	CcSEcCtD
Rufinamide—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000751	0.00304	CcSEcCtD
Rufinamide—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000751	0.00304	CcSEcCtD
Rufinamide—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000746	0.00302	CcSEcCtD
Rufinamide—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.000746	0.00302	CcSEcCtD
Rufinamide—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.000746	0.00302	CcSEcCtD
Rufinamide—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.000746	0.00302	CcSEcCtD
Rufinamide—Infection—Tiotropium—chronic obstructive pulmonary disease	0.000744	0.00301	CcSEcCtD
Rufinamide—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.000741	0.003	CcSEcCtD
Rufinamide—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.000741	0.003	CcSEcCtD
Rufinamide—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000735	0.00297	CcSEcCtD
Rufinamide—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.00073	0.00296	CcSEcCtD
Rufinamide—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000728	0.00294	CcSEcCtD
Rufinamide—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000726	0.00294	CcSEcCtD
Rufinamide—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000724	0.00293	CcSEcCtD
Rufinamide—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000719	0.00291	CcSEcCtD
Rufinamide—Back pain—Formoterol—chronic obstructive pulmonary disease	0.000717	0.0029	CcSEcCtD
Rufinamide—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.000717	0.0029	CcSEcCtD
Rufinamide—Increased appetite—Prednisolone—chronic obstructive pulmonary disease	0.000709	0.00287	CcSEcCtD
Rufinamide—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000708	0.00286	CcSEcCtD
Rufinamide—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000704	0.00285	CcSEcCtD
Rufinamide—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.0007	0.00283	CcSEcCtD
Rufinamide—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000699	0.00283	CcSEcCtD
Rufinamide—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000694	0.00281	CcSEcCtD
Rufinamide—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000694	0.00281	CcSEcCtD
Rufinamide—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000691	0.00279	CcSEcCtD
Rufinamide—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000681	0.00276	CcSEcCtD
Rufinamide—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000681	0.00276	CcSEcCtD
Rufinamide—Tremor—Montelukast—chronic obstructive pulmonary disease	0.00068	0.00275	CcSEcCtD
Rufinamide—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000678	0.00274	CcSEcCtD
Rufinamide—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.000677	0.00274	CcSEcCtD
Rufinamide—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000667	0.0027	CcSEcCtD
Rufinamide—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00066	0.00267	CcSEcCtD
Rufinamide—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000655	0.00265	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000647	0.00262	CcSEcCtD
Rufinamide—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000643	0.0026	CcSEcCtD
Rufinamide—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000641	0.00259	CcSEcCtD
Rufinamide—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000629	0.00254	CcSEcCtD
Rufinamide—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000629	0.00254	CcSEcCtD
Rufinamide—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000629	0.00254	CcSEcCtD
Rufinamide—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000629	0.00254	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000626	0.00253	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000626	0.00253	CcSEcCtD
Rufinamide—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000616	0.00249	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000614	0.00248	CcSEcCtD
Rufinamide—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000601	0.00243	CcSEcCtD
Rufinamide—Infection—Formoterol—chronic obstructive pulmonary disease	0.000601	0.00243	CcSEcCtD
Rufinamide—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000594	0.0024	CcSEcCtD
Rufinamide—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000593	0.0024	CcSEcCtD
Rufinamide—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000593	0.0024	CcSEcCtD
Rufinamide—Infection—Montelukast—chronic obstructive pulmonary disease	0.000588	0.00238	CcSEcCtD
Rufinamide—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000587	0.00238	CcSEcCtD
Rufinamide—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000587	0.00238	CcSEcCtD
Rufinamide—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000585	0.00237	CcSEcCtD
Rufinamide—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000581	0.00235	CcSEcCtD
Rufinamide—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00058	0.00235	CcSEcCtD
Rufinamide—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000575	0.00233	CcSEcCtD
Rufinamide—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000567	0.0023	CcSEcCtD
Rufinamide—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000562	0.00227	CcSEcCtD
Rufinamide—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00056	0.00227	CcSEcCtD
Rufinamide—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000555	0.00224	CcSEcCtD
Rufinamide—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000552	0.00223	CcSEcCtD
Rufinamide—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000547	0.00221	CcSEcCtD
Rufinamide—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000547	0.00221	CcSEcCtD
Rufinamide—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000544	0.0022	CcSEcCtD
Rufinamide—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000544	0.0022	CcSEcCtD
Rufinamide—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000538	0.00218	CcSEcCtD
Rufinamide—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000538	0.00218	CcSEcCtD
Rufinamide—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000536	0.00217	CcSEcCtD
Rufinamide—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000532	0.00215	CcSEcCtD
Rufinamide—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000532	0.00215	CcSEcCtD
Rufinamide—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00053	0.00214	CcSEcCtD
Rufinamide—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000527	0.00213	CcSEcCtD
Rufinamide—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000525	0.00213	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000522	0.00211	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000522	0.00211	CcSEcCtD
Rufinamide—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000521	0.00211	CcSEcCtD
Rufinamide—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000521	0.00211	CcSEcCtD
Rufinamide—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000521	0.00211	CcSEcCtD
Rufinamide—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000517	0.00209	CcSEcCtD
Rufinamide—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000517	0.00209	CcSEcCtD
Rufinamide—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000516	0.00209	CcSEcCtD
Rufinamide—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000515	0.00209	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000511	0.00207	CcSEcCtD
Rufinamide—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000511	0.00207	CcSEcCtD
Rufinamide—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000508	0.00205	CcSEcCtD
Rufinamide—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000505	0.00204	CcSEcCtD
Rufinamide—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000503	0.00203	CcSEcCtD
Rufinamide—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000501	0.00203	CcSEcCtD
Rufinamide—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.0005	0.00203	CcSEcCtD
Rufinamide—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000498	0.00201	CcSEcCtD
Rufinamide—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000496	0.00201	CcSEcCtD
Rufinamide—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000495	0.002	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000493	0.00199	CcSEcCtD
Rufinamide—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000492	0.00199	CcSEcCtD
Rufinamide—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000488	0.00198	CcSEcCtD
Rufinamide—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000476	0.00193	CcSEcCtD
Rufinamide—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000472	0.00191	CcSEcCtD
Rufinamide—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000472	0.00191	CcSEcCtD
Rufinamide—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000472	0.00191	CcSEcCtD
Rufinamide—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000469	0.0019	CcSEcCtD
Rufinamide—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000446	0.0018	CcSEcCtD
Rufinamide—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000446	0.0018	CcSEcCtD
Rufinamide—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000445	0.0018	CcSEcCtD
Rufinamide—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000436	0.00177	CcSEcCtD
Rufinamide—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000434	0.00176	CcSEcCtD
Rufinamide—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000434	0.00176	CcSEcCtD
Rufinamide—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000428	0.00173	CcSEcCtD
Rufinamide—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000428	0.00173	CcSEcCtD
Rufinamide—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000425	0.00172	CcSEcCtD
Rufinamide—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000421	0.0017	CcSEcCtD
Rufinamide—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000419	0.0017	CcSEcCtD
Rufinamide—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000414	0.00167	CcSEcCtD
Rufinamide—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000414	0.00167	CcSEcCtD
Rufinamide—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00041	0.00166	CcSEcCtD
Rufinamide—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000405	0.00164	CcSEcCtD
Rufinamide—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000404	0.00163	CcSEcCtD
Rufinamide—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.0004	0.00162	CcSEcCtD
Rufinamide—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.0004	0.00162	CcSEcCtD
Rufinamide—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000392	0.00158	CcSEcCtD
Rufinamide—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000391	0.00158	CcSEcCtD
Rufinamide—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000391	0.00158	CcSEcCtD
Rufinamide—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000384	0.00156	CcSEcCtD
Rufinamide—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000384	0.00156	CcSEcCtD
Rufinamide—Rash—Formoterol—chronic obstructive pulmonary disease	0.000381	0.00154	CcSEcCtD
Rufinamide—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000381	0.00154	CcSEcCtD
Rufinamide—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000381	0.00154	CcSEcCtD
Rufinamide—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000381	0.00154	CcSEcCtD
Rufinamide—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000379	0.00153	CcSEcCtD
Rufinamide—Headache—Formoterol—chronic obstructive pulmonary disease	0.000379	0.00153	CcSEcCtD
Rufinamide—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000379	0.00153	CcSEcCtD
Rufinamide—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000378	0.00153	CcSEcCtD
Rufinamide—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000378	0.00153	CcSEcCtD
Rufinamide—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000377	0.00152	CcSEcCtD
Rufinamide—Rash—Montelukast—chronic obstructive pulmonary disease	0.000373	0.00151	CcSEcCtD
Rufinamide—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000373	0.00151	CcSEcCtD
Rufinamide—Headache—Montelukast—chronic obstructive pulmonary disease	0.000371	0.0015	CcSEcCtD
Rufinamide—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000363	0.00147	CcSEcCtD
Rufinamide—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000361	0.00146	CcSEcCtD
Rufinamide—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00036	0.00146	CcSEcCtD
Rufinamide—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00036	0.00146	CcSEcCtD
Rufinamide—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000359	0.00145	CcSEcCtD
Rufinamide—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000359	0.00145	CcSEcCtD
Rufinamide—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000358	0.00145	CcSEcCtD
Rufinamide—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000352	0.00142	CcSEcCtD
Rufinamide—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000348	0.00141	CcSEcCtD
Rufinamide—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000339	0.00137	CcSEcCtD
Rufinamide—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000313	0.00127	CcSEcCtD
Rufinamide—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000303	0.00122	CcSEcCtD
Rufinamide—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000296	0.0012	CcSEcCtD
Rufinamide—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000293	0.00119	CcSEcCtD
Rufinamide—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000292	0.00118	CcSEcCtD
Rufinamide—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000275	0.00111	CcSEcCtD
Rufinamide—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.00027	0.00109	CcSEcCtD
Rufinamide—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000268	0.00108	CcSEcCtD
Rufinamide—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000262	0.00106	CcSEcCtD
Rufinamide—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000253	0.00102	CcSEcCtD
Rufinamide—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000247	0.001	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000247	0.000998	CcSEcCtD
Rufinamide—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000241	0.000976	CcSEcCtD
Rufinamide—Infection—Prednisone—chronic obstructive pulmonary disease	0.000236	0.000957	CcSEcCtD
Rufinamide—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000233	0.000944	CcSEcCtD
Rufinamide—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000231	0.000935	CcSEcCtD
Rufinamide—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000227	0.000918	CcSEcCtD
Rufinamide—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000217	0.000876	CcSEcCtD
Rufinamide—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000215	0.000871	CcSEcCtD
Rufinamide—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000209	0.000848	CcSEcCtD
Rufinamide—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000207	0.000837	CcSEcCtD
Rufinamide—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000206	0.000835	CcSEcCtD
Rufinamide—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000206	0.000835	CcSEcCtD
Rufinamide—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000205	0.00083	CcSEcCtD
Rufinamide—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000205	0.00083	CcSEcCtD
Rufinamide—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000204	0.000823	CcSEcCtD
Rufinamide—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000195	0.000787	CcSEcCtD
Rufinamide—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000175	0.000709	CcSEcCtD
Rufinamide—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000171	0.000691	CcSEcCtD
Rufinamide—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000168	0.000681	CcSEcCtD
Rufinamide—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000163	0.000659	CcSEcCtD
Rufinamide—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000157	0.000637	CcSEcCtD
Rufinamide—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000151	0.000612	CcSEcCtD
Rufinamide—Rash—Prednisone—chronic obstructive pulmonary disease	0.00015	0.000607	CcSEcCtD
Rufinamide—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.00015	0.000607	CcSEcCtD
Rufinamide—Headache—Prednisone—chronic obstructive pulmonary disease	0.000149	0.000603	CcSEcCtD
Rufinamide—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000141	0.000572	CcSEcCtD
Rufinamide—ALB—Folate Metabolism—CRP—chronic obstructive pulmonary disease	0.0001	0.00256	CbGpPWpGaD
Rufinamide—CYP2E1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.0001	0.00255	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	9.87e-05	0.00252	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	9.83e-05	0.00251	CbGpPWpGaD
Rufinamide—SCN7A—Axon guidance—VEGFA—chronic obstructive pulmonary disease	9.58e-05	0.00244	CbGpPWpGaD
Rufinamide—SCN11A—Axon guidance—MMP9—chronic obstructive pulmonary disease	9.5e-05	0.00243	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	9.47e-05	0.00242	CbGpPWpGaD
Rufinamide—ALB—Vitamin B12 Metabolism—SERPINE1—chronic obstructive pulmonary disease	9.47e-05	0.00242	CbGpPWpGaD
Rufinamide—SCN5A—L1CAM interactions—EGFR—chronic obstructive pulmonary disease	9.37e-05	0.00239	CbGpPWpGaD
Rufinamide—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	9.27e-05	0.00237	CbGpPWpGaD
Rufinamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	9.07e-05	0.00231	CbGpPWpGaD
Rufinamide—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	8.95e-05	0.00228	CbGpPWpGaD
Rufinamide—SCN8A—Axon guidance—MMP9—chronic obstructive pulmonary disease	8.69e-05	0.00222	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	8.69e-05	0.00222	CbGpPWpGaD
Rufinamide—SCN7A—Axon guidance—EGFR—chronic obstructive pulmonary disease	8.62e-05	0.0022	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	8.6e-05	0.0022	CbGpPWpGaD
Rufinamide—SCN11A—Axon guidance—VEGFA—chronic obstructive pulmonary disease	8.53e-05	0.00218	CbGpPWpGaD
Rufinamide—CYP2E1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	8.42e-05	0.00215	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	8.37e-05	0.00214	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—LEP—chronic obstructive pulmonary disease	8.35e-05	0.00213	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	8.34e-05	0.00213	CbGpPWpGaD
Rufinamide—CYP2E1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	8.3e-05	0.00212	CbGpPWpGaD
Rufinamide—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	8.15e-05	0.00208	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—LEP—chronic obstructive pulmonary disease	7.98e-05	0.00204	CbGpPWpGaD
Rufinamide—ALB—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	7.97e-05	0.00203	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	7.9e-05	0.00202	CbGpPWpGaD
Rufinamide—SCN8A—Axon guidance—VEGFA—chronic obstructive pulmonary disease	7.81e-05	0.00199	CbGpPWpGaD
Rufinamide—ALB—Folate Metabolism—SERPINE1—chronic obstructive pulmonary disease	7.7e-05	0.00197	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—SERPINA1—chronic obstructive pulmonary disease	7.7e-05	0.00196	CbGpPWpGaD
Rufinamide—ALB—Vitamin B12 Metabolism—IL1B—chronic obstructive pulmonary disease	7.69e-05	0.00196	CbGpPWpGaD
Rufinamide—SCN11A—Axon guidance—EGFR—chronic obstructive pulmonary disease	7.68e-05	0.00196	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—LEP—chronic obstructive pulmonary disease	7.67e-05	0.00196	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—LEP—chronic obstructive pulmonary disease	7.67e-05	0.00196	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—MMP9—chronic obstructive pulmonary disease	7.61e-05	0.00194	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	7.58e-05	0.00193	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—LEP—chronic obstructive pulmonary disease	7.4e-05	0.00189	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—LEP—chronic obstructive pulmonary disease	7.4e-05	0.00189	CbGpPWpGaD
Rufinamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	7.35e-05	0.00188	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	7.06e-05	0.0018	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—KL—chronic obstructive pulmonary disease	7.04e-05	0.0018	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—MMP9—chronic obstructive pulmonary disease	7.03e-05	0.00179	CbGpPWpGaD
Rufinamide—SCN8A—Axon guidance—EGFR—chronic obstructive pulmonary disease	7.02e-05	0.00179	CbGpPWpGaD
Rufinamide—CYP2E1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.02e-05	0.00179	CbGpPWpGaD
Rufinamide—CYP2E1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.92e-05	0.00177	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	6.91e-05	0.00176	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	6.83e-05	0.00174	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—MMP9—chronic obstructive pulmonary disease	6.78e-05	0.00173	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—MMP9—chronic obstructive pulmonary disease	6.72e-05	0.00172	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—TGFB2—chronic obstructive pulmonary disease	6.67e-05	0.0017	CbGpPWpGaD
Rufinamide—SCN7A—Axon guidance—IL6—chronic obstructive pulmonary disease	6.62e-05	0.00169	CbGpPWpGaD
Rufinamide—ALB—Platelet degranulation—SERPINE1—chronic obstructive pulmonary disease	6.6e-05	0.00169	CbGpPWpGaD
Rufinamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	6.59e-05	0.00168	CbGpPWpGaD
Rufinamide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	6.5e-05	0.00166	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	6.5e-05	0.00166	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—MMP9—chronic obstructive pulmonary disease	6.46e-05	0.00165	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—MMP9—chronic obstructive pulmonary disease	6.46e-05	0.00165	CbGpPWpGaD
Rufinamide—CYP2E1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.45e-05	0.00165	CbGpPWpGaD
Rufinamide—CYP2E1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.36e-05	0.00162	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—VEGFA—chronic obstructive pulmonary disease	6.31e-05	0.00161	CbGpPWpGaD
Rufinamide—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—chronic obstructive pulmonary disease	6.29e-05	0.00161	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	6.27e-05	0.0016	CbGpPWpGaD
Rufinamide—ALB—Folate Metabolism—IL1B—chronic obstructive pulmonary disease	6.26e-05	0.0016	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—MMP9—chronic obstructive pulmonary disease	6.23e-05	0.00159	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—MMP9—chronic obstructive pulmonary disease	6.23e-05	0.00159	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—MMP9—chronic obstructive pulmonary disease	6.2e-05	0.00158	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	6.15e-05	0.00157	CbGpPWpGaD
Rufinamide—ALB—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	6.12e-05	0.00156	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	6.12e-05	0.00156	CbGpPWpGaD
Rufinamide—CYP2E1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.12e-05	0.00156	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	6.09e-05	0.00155	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	6.05e-05	0.00154	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—VEGFA—chronic obstructive pulmonary disease	6.04e-05	0.00154	CbGpPWpGaD
Rufinamide—CYP2E1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.03e-05	0.00154	CbGpPWpGaD
Rufinamide—SCN11A—Axon guidance—IL6—chronic obstructive pulmonary disease	5.9e-05	0.00151	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—TNF—chronic obstructive pulmonary disease	5.86e-05	0.00149	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	5.85e-05	0.00149	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	5.81e-05	0.00148	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—VEGFA—chronic obstructive pulmonary disease	5.8e-05	0.00148	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—VEGFA—chronic obstructive pulmonary disease	5.8e-05	0.00148	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—EGFR—chronic obstructive pulmonary disease	5.68e-05	0.00145	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—VEGFA—chronic obstructive pulmonary disease	5.59e-05	0.00143	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—VEGFA—chronic obstructive pulmonary disease	5.59e-05	0.00143	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	5.59e-05	0.00143	CbGpPWpGaD
Rufinamide—ALB—Vitamin B12 Metabolism—TNF—chronic obstructive pulmonary disease	5.58e-05	0.00142	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	5.57e-05	0.00142	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	5.48e-05	0.0014	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—EGFR—chronic obstructive pulmonary disease	5.43e-05	0.00139	CbGpPWpGaD
Rufinamide—SCN8A—Axon guidance—IL6—chronic obstructive pulmonary disease	5.4e-05	0.00138	CbGpPWpGaD
Rufinamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	5.34e-05	0.00136	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	5.31e-05	0.00136	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	5.28e-05	0.00135	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—EGFR—chronic obstructive pulmonary disease	5.22e-05	0.00133	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—EGFR—chronic obstructive pulmonary disease	5.22e-05	0.00133	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—TNF—chronic obstructive pulmonary disease	5.22e-05	0.00133	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—LEP—chronic obstructive pulmonary disease	5.2e-05	0.00133	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	5.11e-05	0.0013	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	5.08e-05	0.0013	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—EGFR—chronic obstructive pulmonary disease	5.03e-05	0.00128	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—EGFR—chronic obstructive pulmonary disease	5.03e-05	0.00128	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—MMP9—chronic obstructive pulmonary disease	5.02e-05	0.00128	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	5.01e-05	0.00128	CbGpPWpGaD
Rufinamide—ALB—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	4.97e-05	0.00127	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—APIP—chronic obstructive pulmonary disease	4.92e-05	0.00126	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	4.88e-05	0.00125	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—MMP9—chronic obstructive pulmonary disease	4.8e-05	0.00122	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—TNF—chronic obstructive pulmonary disease	4.77e-05	0.00122	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—IL6—chronic obstructive pulmonary disease	4.73e-05	0.00121	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.72e-05	0.00121	CbGpPWpGaD
Rufinamide—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	4.7e-05	0.0012	CbGpPWpGaD
Rufinamide—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	4.64e-05	0.00119	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—MMP9—chronic obstructive pulmonary disease	4.61e-05	0.00118	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—MMP9—chronic obstructive pulmonary disease	4.61e-05	0.00118	CbGpPWpGaD
Rufinamide—ALB—Platelet degranulation—VEGFA—chronic obstructive pulmonary disease	4.54e-05	0.00116	CbGpPWpGaD
Rufinamide—ALB—Folate Metabolism—TNF—chronic obstructive pulmonary disease	4.54e-05	0.00116	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	4.51e-05	0.00115	CbGpPWpGaD
Rufinamide—ALB—Vitamin B12 Metabolism—IL6—chronic obstructive pulmonary disease	4.5e-05	0.00115	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—MMP9—chronic obstructive pulmonary disease	4.45e-05	0.00113	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—MMP9—chronic obstructive pulmonary disease	4.45e-05	0.00113	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—MMP9—chronic obstructive pulmonary disease	4.38e-05	0.00112	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—IL6—chronic obstructive pulmonary disease	4.37e-05	0.00111	CbGpPWpGaD
Rufinamide—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—chronic obstructive pulmonary disease	4.33e-05	0.0011	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	4.31e-05	0.0011	CbGpPWpGaD
Rufinamide—ALB—Metabolism—APIP—chronic obstructive pulmonary disease	4.23e-05	0.00108	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—IL6—chronic obstructive pulmonary disease	4.21e-05	0.00108	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—IL6—chronic obstructive pulmonary disease	4.18e-05	0.00107	CbGpPWpGaD
Rufinamide—ALB—Platelet degranulation—TGFB1—chronic obstructive pulmonary disease	4.17e-05	0.00106	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	4.14e-05	0.00106	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	4.14e-05	0.00106	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	4.14e-05	0.00106	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	4.05e-05	0.00103	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—IL6—chronic obstructive pulmonary disease	4.01e-05	0.00102	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—IL6—chronic obstructive pulmonary disease	4.01e-05	0.00102	CbGpPWpGaD
Rufinamide—ALB—Folate Metabolism—TP53—chronic obstructive pulmonary disease	4e-05	0.00102	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	3.99e-05	0.00102	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	3.99e-05	0.00102	CbGpPWpGaD
Rufinamide—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	3.97e-05	0.00101	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	3.97e-05	0.00101	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	3.96e-05	0.00101	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—VEGFA—chronic obstructive pulmonary disease	3.93e-05	0.001	CbGpPWpGaD
Rufinamide—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.9e-05	0.000997	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.88e-05	0.000991	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	3.88e-05	0.00099	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—IL6—chronic obstructive pulmonary disease	3.87e-05	0.000987	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—IL6—chronic obstructive pulmonary disease	3.87e-05	0.000987	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—TNF—chronic obstructive pulmonary disease	3.86e-05	0.000985	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—IL6—chronic obstructive pulmonary disease	3.85e-05	0.000983	CbGpPWpGaD
Rufinamide—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.85e-05	0.000983	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	3.8e-05	0.00097	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	3.8e-05	0.00097	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	3.73e-05	0.000951	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	3.73e-05	0.000951	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.71e-05	0.000946	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—TNF—chronic obstructive pulmonary disease	3.69e-05	0.000943	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	3.66e-05	0.000935	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	3.66e-05	0.000935	CbGpPWpGaD
Rufinamide—ALB—Folate Metabolism—IL6—chronic obstructive pulmonary disease	3.66e-05	0.000935	CbGpPWpGaD
Rufinamide—ALB—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	3.61e-05	0.00092	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	3.59e-05	0.000917	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	3.59e-05	0.000917	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—TNF—chronic obstructive pulmonary disease	3.55e-05	0.000906	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—TNF—chronic obstructive pulmonary disease	3.55e-05	0.000906	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—EGFR—chronic obstructive pulmonary disease	3.54e-05	0.000903	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.54e-05	0.000903	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—TGFB2—chronic obstructive pulmonary disease	3.44e-05	0.000878	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—TNF—chronic obstructive pulmonary disease	3.42e-05	0.000873	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—TNF—chronic obstructive pulmonary disease	3.42e-05	0.000873	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.26e-05	0.000832	CbGpPWpGaD
Rufinamide—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.26e-05	0.000831	CbGpPWpGaD
Rufinamide—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.21e-05	0.00082	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GC—chronic obstructive pulmonary disease	3.17e-05	0.000809	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.14e-05	0.000801	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—MMP9—chronic obstructive pulmonary disease	3.13e-05	0.000798	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—IL6—chronic obstructive pulmonary disease	3.12e-05	0.000795	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—HDAC2—chronic obstructive pulmonary disease	3.09e-05	0.000787	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.01e-05	0.000769	CbGpPWpGaD
Rufinamide—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.99e-05	0.000764	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.99e-05	0.000762	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—IL6—chronic obstructive pulmonary disease	2.98e-05	0.000761	CbGpPWpGaD
Rufinamide—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.95e-05	0.000753	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.95e-05	0.000752	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	2.93e-05	0.000747	CbGpPWpGaD
Rufinamide—ALB—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	2.91e-05	0.000743	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—IL6—chronic obstructive pulmonary disease	2.86e-05	0.000731	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—IL6—chronic obstructive pulmonary disease	2.86e-05	0.000731	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.84e-05	0.000725	CbGpPWpGaD
Rufinamide—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.84e-05	0.000724	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	2.81e-05	0.000716	CbGpPWpGaD
Rufinamide—ALB—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.8e-05	0.000715	CbGpPWpGaD
Rufinamide—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.8e-05	0.000714	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PLAUR—chronic obstructive pulmonary disease	2.78e-05	0.00071	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.78e-05	0.000709	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—IL6—chronic obstructive pulmonary disease	2.76e-05	0.000705	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—IL6—chronic obstructive pulmonary disease	2.76e-05	0.000705	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GC—chronic obstructive pulmonary disease	2.72e-05	0.000695	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—IL6—chronic obstructive pulmonary disease	2.72e-05	0.000694	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	2.58e-05	0.000657	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.55e-05	0.000651	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.53e-05	0.000646	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	2.53e-05	0.000645	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—TNF—chronic obstructive pulmonary disease	2.41e-05	0.000614	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.34e-05	0.000597	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.29e-05	0.000586	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.28e-05	0.000583	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.17e-05	0.000554	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.02e-05	0.000515	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	2.01e-05	0.000514	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—MMP1—chronic obstructive pulmonary disease	1.99e-05	0.000507	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PLAU—chronic obstructive pulmonary disease	1.95e-05	0.000498	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—IL6—chronic obstructive pulmonary disease	1.94e-05	0.000495	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.93e-05	0.000492	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	1.85e-05	0.000472	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—NOS2—chronic obstructive pulmonary disease	1.79e-05	0.000458	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.76e-05	0.00045	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.73e-05	0.000442	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.71e-05	0.000437	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.56e-05	0.000399	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.51e-05	0.000386	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	1.51e-05	0.000385	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.49e-05	0.00038	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GCLC—chronic obstructive pulmonary disease	1.47e-05	0.000375	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.47e-05	0.000375	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—NOS3—chronic obstructive pulmonary disease	1.44e-05	0.000368	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.44e-05	0.000367	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.37e-05	0.000349	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CTGF—chronic obstructive pulmonary disease	1.34e-05	0.000343	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.24e-05	0.000316	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.2e-05	0.000306	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.18e-05	0.000302	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.1e-05	0.000282	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.05e-05	0.000267	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—VEGFA—chronic obstructive pulmonary disease	1.04e-05	0.000265	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.03e-05	0.000263	CbGpPWpGaD
Rufinamide—ALB—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.02e-05	0.00026	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—TGFB1—chronic obstructive pulmonary disease	9.53e-06	0.000243	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.48e-06	0.000242	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.99e-06	0.000229	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.03e-06	0.000205	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	7.94e-06	0.000203	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—TP53—chronic obstructive pulmonary disease	7.85e-06	0.0002	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	7.25e-06	0.000185	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ALB—chronic obstructive pulmonary disease	7.11e-06	0.000181	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—NOS3—chronic obstructive pulmonary disease	6.8e-06	0.000174	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.68e-06	0.00017	CbGpPWpGaD
Rufinamide—ALB—Metabolism—NOS3—chronic obstructive pulmonary disease	5.84e-06	0.000149	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.57e-06	0.000142	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.49e-06	0.00014	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.12e-06	0.000131	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.85e-06	0.000124	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	3.3e-06	8.42e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	3.15e-06	8.05e-05	CbGpPWpGaD
